Your session is about to expire
← Back to Search
Lifestyle Interventions for Prediabetes
Study Summary
This trial will recruit 300 community members in Acoma Pueblo, New Mexico to identify those with pre-diabetes. Of those, 150 will be enrolled in a 16-week lifestyle intervention program with the goal of improving risk factor profiles for diabetes, obesity, and heart disease.
- Prediabetes
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Do I qualify to partake in this experiment?
"Individuals aged 21 to 60 with glucose intolerance are eligible for this trial, which is looking to recruit a total of 150 patients."
Are there currently any vacancies for participation in this clinical experiment?
"Judging from the data on clinicaltrials.gov, this trial is actively seeking participants. The research was posted to the website in May 2022 and its information was last revised at the end of March 2022."
What overarching goals are the researchers hoping to achieve with this experiment?
"This medical trial will track Change in BMI over an extended period of 4, 12 and 16 months for the intervention group, as well as 28 months for the control/delayed intervention group. Additionally, Patient Activation Measure (PAM) scores, fasting lipid panels and fasting blood glucose levels will be observed to determine secondary outcomes. The PAM survey is composed of 13 questions with a scoring range from 0-100; HDL, LDL cholesterol and triglycerides values are also recorded while i-STAT system readings measure changes in fasted glucose levels throughout the study's duration."
Does this research require participants to be of a certain age?
"The age requirements to be enrolled in this trial are between 21 and 60 years."
How many participants has the clinical trial recruited thus far?
"Affirmative. Clinicaltrials.gov has the data to suggest that this trial is presently recruiting patients, having been first published on May 1st 2022 and edited as recently as March 15th 2022. A total of 150 participants are sought from one single site for inclusion in the study."
Share this study with friends
Copy Link
Messenger